Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANTX

AN2 Therapeutics Inc

May 12 • 04:00PM ET

4.27

-0.45 -9.53 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: IMUX OCGN ADAG TNXP PALI

| Held by: VTI VXF IWC DFAS DFMC DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.10	Insider Own	26.52%	Shs Outstand	35.99M	Perf Week	-8.96%
Market Cap	153.79M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.52%	Shs Float	26.45M	Perf Month	41.86%
Enterprise Value	68.50M	PEG	-	EPS next Q	-	Inst Own	42.77%	Short Float	3.33%	Perf Quarter	288.18%
Income	-34.55M	P/S	-	EPS this Y	-	Inst Trans	-1.11%	Short Ratio	0.60	Perf Half Y	274.56%
Sales	0.00M	P/B	1.88	EPS next Y	-	ROA	-40.93%	Short Interest	0.88M	Perf YTD	274.56%
Book/sh	2.27	P/C	1.80	EPS next 5Y	-	ROE	-44.56%	52W High	6.91 -38.20%	Perf Year	258.82%
Cash/sh	2.37	P/FCF	-	EPS past 3/5Y	19.17% -8.39%	ROIC	-42.26%	52W Low	1.00 327.00%	Perf 3Y	-16.11%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.43% 9.24%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.21%	Oper. Margin	-	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.73	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.41	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.73	EPS Q/Q	16.91%	SMA20	-0.40%	Beta	-0.97	Target Price	1.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	9.35%	Rel Volume	0.13	Prev Close	4.72
Employees	21	LT Debt/Eq	0.00	Earnings	May 11 AMC	SMA200	131.56%	Avg Volume	1.47M	Price	4.27
IPO	Mar 25, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	189,026	Change	-9.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)